Chien-Hung Chen (C-H Chen, Tsung H Hu)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 35

Top Topics

Patients Undergoing

Hepatitis C Virus

Prognostic Factors

Ejection Fraction

Top Venues

Alimentary pharmacology & therapeutics

Liver international : official journal of the International Association for the Study of the Liver

This page only lists publications with an associated author ORCID identifier.

Publications

Chien-Hung Chen
Should we expand treatment initiation for chronic hepatitis B infection? Cons. Clinical liver disease 23 (1) (2024)
Chien-Hung Chen
Should we expand treatment initiation for chronic hepatitis B infection? Cons. Clinical liver disease 23 (1) (2024)
Chien-Hung Chen, Cheng-Yuan Peng
Letter: Estimating the incidence of HBsAg seroclearance after cessation of tenofovir and entecavir-potential influence of censored observation. Authors' reply. Alimentary pharmacology & therapeutics 59 (1) (2023)
Chien-Hung Chen, Cheng-Yuan Peng
Letter: Estimating the incidence of HBsAg seroclearance after cessation of tenofovir and entecavir-potential influence of censored observation. Authors' reply. Alimentary pharmacology & therapeutics 59 (1) (2023)
Yuan-Hung Kuo, Tzu-Hsin Huang, Yi-Hao Yen, Sheng-Nan Lu, Jing-Houng Wang, Chao-Hung Hung, Chien-Hung Chen, Ming-Chao Tsai, Kwong-Ming Kee
Nomogram to Predict the Long-Term Overall Survival of Early-Stage Hepatocellular Carcinoma after Radiofrequency Ablation. Cancers 15 (12) (2023)
Chih-Chien Yao, Jing-Houng Wang, Chien-Hung Chen, Chao-Hung Hung, Yi-Hao Yen, Kwong-Ming Kee, Tsung-Hui Hu, Ming-Chao Tsai, Yuan-Hung Kuo, Sheng-Nan Lu
Short Half-Life of Des-γ-Carboxy Prothrombin Is a Superior Factor for Early Prediction of Outcomes of Hepatocellular Carcinoma Treated with Radiofrequency Ablation. Diagnostics (Basel, Switzerland) 13 (4) (2023)
Chien-Hung Chen, Cheng-Yuan Peng, Tsung-Hui Hu, Jing-Houng Wang, Chao-Hung Hung, Sheng-Nan Lu
Higher rate of HBsAg loss after discontinuation of tenofovir than entecavir in patients with chronic hepatitis B. Alimentary pharmacology & therapeutics (2023)
Chih-Chien Yao, Jing-Houng Wang, Chien-Hung Chen, Chao-Hung Hung, Yi-Hao Yen, Kwong-Ming Kee, Tsung-Hui Hu, Ming-Chao Tsai, Yuan-Hung Kuo, Sheng-Nan Lu
Short Half-Life of Des-γ-Carboxy Prothrombin Is a Superior Factor for Early Prediction of Outcomes of Hepatocellular Carcinoma Treated with Radiofrequency Ablation. Diagnostics (Basel, Switzerland) 13 (4) (2023)
Chih-Chien Yao, Jing-Houng Wang, Chien-Hung Chen, Chao-Hung Hung, Yi-Hao Yen, Kwong-Ming Kee, Tsung-Hui Hu, Ming-Chao Tsai, Yuan-Hung Kuo, Sheng-Nan Lu
Short Half-Life of Des-γ-Carboxy Prothrombin Is a Superior Factor for Early Prediction of Outcomes of Hepatocellular Carcinoma Treated with Radiofrequency Ablation. Diagnostics (Basel, Switzerland) 13 (4) (2023)
Chien-Hung Chen, Cheng-Yuan Peng
Letter: Estimating the incidence of HBsAg seroclearance after cessation of tenofovir and entecavir-potential influence of censored observation. Authors' reply. Alimentary pharmacology & therapeutics 59 (1) (2023)
Yuan-Hung Kuo, Tzu-Hsin Huang, Yi-Hao Yen, Sheng-Nan Lu, Jing-Houng Wang, Chao-Hung Hung, Chien-Hung Chen, Ming-Chao Tsai, Kwong-Ming Kee
Nomogram to Predict the Long-Term Overall Survival of Early-Stage Hepatocellular Carcinoma after Radiofrequency Ablation. Cancers 15 (12) (2023)
Chien-Hung Chen, Tsung-Hui Hu, Jing-Houng Wang, Hsueh-Chou Lai, Chao-Hung Hung, Sheng-Nan Lu, Cheng-Yuan Peng
A Mac-2 Binding Protein Glycosylation Isomer-Based Risk Model Predicts Hepatocellular Carcinoma in HBV-Related Cirrhotic Patients on Antiviral Therapy. Cancers 14 (20) (2022)
Kuo-Chin Chang, Ming-Tsung Lin, Jing-Houng Wang, Chao-Hung Hung, Chien-Hung Chen, Sherry Yueh-Hsia Chiu, Tsung-Hui Hu
HBcrAg Predicts Hepatocellular Carcinoma Development in Chronic B Hepatitis Related Liver Cirrhosis Patients Undergoing Long-Term Effective Anti-Viral. Viruses 14 (12) (2022)
Kuo-Chin Chang, Ming-Tsung Lin, Jing-Houng Wang, Chao-Hung Hung, Chien-Hung Chen, Sherry Yueh-Hsia Chiu, Tsung-Hui Hu
HBcrAg Predicts Hepatocellular Carcinoma Development in Chronic B Hepatitis Related Liver Cirrhosis Patients Undergoing Long-Term Effective Anti-Viral. Viruses 14 (12) (2022)
Tzu-Ning Tseng, Chien-Hung Chen
Editorial: changes in renal function and bone mineral density after switching from tenofovir disoproxil fumarate to tenofovir alafenamide in patients with chronic hepatitis B. Alimentary pharmacology & therapeutics 56 (5) (2022)
Kuo-Chin Chang, Ming-Tsung Lin, Jing-Houng Wang, Chao-Hung Hung, Chien-Hung Chen, Sherry Yueh-Hsia Chiu, Tsung-Hui Hu
HBcrAg Predicts Hepatocellular Carcinoma Development in Chronic B Hepatitis Related Liver Cirrhosis Patients Undergoing Long-Term Effective Anti-Viral. Viruses 14 (12) (2022)
Shao-Ming Chiu, Kuo-Chin Chang, Tsung-Hui Hu, Chao-Hung Hung, Jing-Houng Wang, Sheng-Nan Lu, Chien-Hung Chen
Retreatment Efficacy and Renal Safety of Tenofovir Alafenamide, Entecavir, and Tenofovir Disoproxil Fumarate After Entecavir or Tenofovir Cessation. Digestive diseases and sciences (2022)
Chi-Yi Chen, Wan-Long Chuang, Albert Qin, Wen-Hua Zhang, Li-Ying Zhu, Guo-Qiang Zhang, Jyh-Jou Chen, Ching-Chu Lo, Xinmin Zhou, Xiaorong Mao, Jia Shang, Hsing-Tao Kuo, Wen Xie, Chien-Hung Chen, Gin-Ho Lo, Dae Won Jun, Shuangsuo Dang, Chan-Yen Tsai, Ting-Fang Wang, Hsin-Hui Lai, Kuan-Chiao Tseng, Yi-Wen Huang, Pei-Jer Chen
A Phase 3 clinical trial validating the potency and safety of an innovative, extra-long-acting interferon in chronic hepatitis C. JGH open : an open access journal of gastroenterology and hepatology 6 (11) (2022)
Kuo-Chin Chang, Ming-Tsung Lin, Jing-Houng Wang, Chao-Hung Hung, Chien-Hung Chen, Sherry Yueh-Hsia Chiu, Tsung-Hui Hu
HBcrAg Predicts Hepatocellular Carcinoma Development in Chronic B Hepatitis Related Liver Cirrhosis Patients Undergoing Long-Term Effective Anti-Viral. Viruses 14 (12) (2022)
Kuo-Chin Chang, Ming-Tsung Lin, Jing-Houng Wang, Chao-Hung Hung, Chien-Hung Chen, Sherry Yueh-Hsia Chiu, Tsung-Hui Hu
HBcrAg Predicts Hepatocellular Carcinoma Development in Chronic B Hepatitis Related Liver Cirrhosis Patients Undergoing Long-Term Effective Anti-Viral. Viruses 14 (12) (2022)
Tzu-Ning Tseng, Yuan-Hung Kuo, Tsung-Hui Hu, Chao-Hung Hung, Jing-Houng Wang, Sheng-Nan Lu, Chien-Hung Chen
Kinetics in HBsAg after Stopping Entecavir or Tenofovir in Patients with Virological Relapse but Not Clinical Relapse. Viruses 14 (6) (2022)
Chi-Yi Chen, Chung-Feng Huang, Pin-Nan Cheng, Kuo-Chih Tseng, Ching-Chu Lo, Hsing-Tao Kuo, Yi-Hsiang Huang, Chi-Ming Tai, Cheng-Yuan Peng, Ming-Jong Bair, Chien-Hung Chen, Ming-Lun Yeh, Chih-Lang Lin, Yung-Chang Lin, Pei-Lun Lee, Lee-Won Chong, Chao-Hung Hung, Jee-Fu Huang, Chi-Chieh Yang, Jui-Ting Hu, Chih-Wen Lin, Chun-Ting Chen, Chia-Chi Wang, Wei-Wen Su, Tsai-Yuan Hsieh, Chih-Lin Lin, Wei-Lun Tsai, Tzong-Hsi Lee, Guei-Ying Chen, Szu-Jen Wang, Chun-Chao Chang, Lein-Ray Mo, Sheng-Shun Yang, Wen-Chih Wu, Chia-Sheng Huang, Chou-Kwok Hsiung, Chien-Neng Kao, Pei-Chien Tsai, Chen-Hua Liu, Mei-Hsuan Lee, Chun-Jen Liu, Chia-Yen Dai, Jia-Horng Kao, Wan-Long Chuang, Han-Chieh Lin, Ming-Lung Yu
Factors associated with treatment failure of direct-acting antivirals for chronic hepatitis C: A real-world nationwide hepatitis C virus registry programme in Taiwan. Liver international : official journal of the International Association for the Study of the Liver 41 (6) (2021)
Hsin-Wei Fang, Yi-Hao Yen, Chao-Hung Hung, Jing-Houng Wang, Tsung-Hui Hu, Sheng-Nan Lu, Chien-Hung Chen
Predictors of Virological Suppression After Clinical Relapse in Patients Who Discontinued Entecavir or Tenofovir. Digestive diseases and sciences (2021)
Cheng-Yuan Peng, Chien-Hung Chen
On-treatment predictors of hepatocellular carcinoma in patients with chronic hepatitis B. Liver international : official journal of the International Association for the Study of the Liver 41 (7) (2021)
Tsung-Hui Hu, Sherry Yueh-Hsia Chiu, Po-Lin Tseng, Chien-Hung Chen, Sheng-Nan Lu, Jing-Houng Wang, Chao-Hung Hung, Kwong-Ming Kee, Ming-Tsung Lin, Kuo-Chin Chang, Meng-Chih Lin, Rong-Nan Chien
Five-year comparative risk of hepatocellular carcinoma development under entecavir or tenofovir treatment-naïve patients with chronic hepatitis B-related compensated cirrhosis in Taiwan. Alimentary pharmacology & therapeutics 52 (11-12) (2020)
Chien-Hung Chen
Letter: distinct hepatitis B virus relapse rates after discontinuing tenofovir and entecavir therapy in chronic hepatitis B patients-author's reply. Alimentary pharmacology & therapeutics 49 (8) (2020)
Chris Estes, Henry Lik Yuen Chan, Rong N Chien, Wan-Long Chuang, James Fung, George Boon-Bee Goh, Chien-Hung Chen, Jee-Fu Huang, Byoung K Jang, Dae Won Jun, Jia H Kao, Jin-Woo Lee, Han-Chieh Lin, Kathryn Razavi-Shearer, Wai Kay Seto, Grace Lai-Hung Wong, Vincent Wai-Sun Wong, Homie Razavi
Modelling NAFLD disease burden in four Asian regions-2019-2030. Alimentary pharmacology & therapeutics 51 (8) (2020)
Yuan-Hung Kuo, Jing-Houng Wang, Kuo-Chin Chang, Chao-Hung Hung, Sheng-Nan Lu, Tsung-Hui Hu, Yi-Hao Yen, Kwong-Ming Kee, Chien-Hung Chen
The influence of direct-acting antivirals in hepatitis C virus related hepatocellular carcinoma after curative treatment. Investigational new drugs 38 (1) (2019)
Te-Ling Ma, Tsung-Hui Hu, Chao-Hung Hung, Jing-Houng Wang, Sheng-Nan Lu, Chien-Hung Chen
Incidence and predictors of retreatment in chronic hepatitis B patients after discontinuation of entecavir or tenofovir treatment. PloS one 14 (10) (2019)
Chien-Hung Chen, Yao-Chun Hsu, S-N Lu, C-H Hung, J-H Wang, C-M Lee, Tsung-Hui Hu
The incidence and predictors of HBV relapse after cessation of tenofovir therapy in chronic hepatitis B patients. Journal of viral hepatitis 25 (5) (2018)
Ming-Te Kuo, Tsung-Hui Hu, Chao-Hung Hung, Jing-Houng Wang, Sheng-Nan Lu, Kai-Lung Tsai, Chien-Hung Chen
Hepatitis B virus relapse rates in chronic hepatitis B patients who discontinue either entecavir or tenofovir. Alimentary pharmacology & therapeutics 49 (2) (2018)
Hung-Hsien Chiang, Chuan-Mo Lee, Tsung-Hui Hu, Chao-Hung Hung, Jing-Houng Wang, Sheng-Nan Lu, Hsueh-Chou Lai, Wen-Pang Su, Chia-Hsin Lin, Cheng-Yuan Peng, Chien-Hung Chen
A combination of the on-treatment FIB-4 and alpha-foetoprotein predicts clinical outcomes in cirrhotic patients receiving entecavir. Liver international : official journal of the International Association for the Study of the Liver 38 (11) (2018)
C-H Hung, J-H Wang, S-N Lu, T-H Hu, C-M Lee, Chien-Hung Chen
Hepatitis B surface antigen loss and clinical outcomes between HBeAg-negative cirrhosis patients who discontinued or continued nucleoside analogue therapy. Journal of viral hepatitis 24 (7) (2017)
Chien-Hung Chen
Editorial: hepatitis B reactivation in patients with chronic hepatitis C treated with direct-acting antivirals - incidence, severity of hepatitis and lessons to learn. Alimentary pharmacology & therapeutics 45 (10) (2017)
Yi-Hao Yen, Ming-Tsung Lin, Fang-Ying Kuo, Kuo-Chin Chang, Ming-Chao Tsai, Po-Lin Tseng, Cheng-Kun Wu, Jung-Ting Lin, Tsung-Hui Hu, Sheng-Nan Lu, Jing-Houng Wang, Chao-Hung Hung, Chien-Hung Chen
The association between steatosis and diabetes with hepatocellular carcinoma in non-genotype 3 chronic hepatitis C patients. Liver international : official journal of the International Association for the Study of the Liver 38 (6) (2017)